Venture Shape

Venture Shape helps biotech companies define the main case for why they matter to investors, then carries that narrative across the materials investors see. It works with biotech executives and the investor relations, public relations and communications teams that support them before a raise, clinical data announcement, Investor Day, R&D Day or conference.

Biotech investor stories often break between the deck, the website and the scientific figures.

The first engagement is an Investor Story Sprint. In ten business days, Venture Shape reviews the current deck, relevant website pages and latest company update. The sprint produces a short outline of the investor case, a rewritten opening sequence and a prioritized list of the writing, design and development work needed before the next event.

Venture Shape also restructures investor decks, redesigns and develops investor-facing websites, and creates scientific visuals that make mechanisms, programs, pipelines and milestones easier to understand.

It also works with biotech investor relations, public relations and communications teams when a client deadline requires additional production help.

If you have a dated investor event in the next 90 days, send the date and what needs to be ready.